Related Experiment Video

Updated: May 7, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis

Anis Chaari1, Basma Mnif, Mabrouk Bahloul

  • 1Intensive Care Unit, Faculty of Medicine, University of Sfax, Hôpital Habib Bourguiba, Route el Ain Km 1, 3029 Sfax, Tunisia.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|October 8, 2013
PubMed
Abstract

Insights

Acinetobacter baumannii ventilator-associated pneumonia (VAP) has a high mortality rate, with septic shock and hypertension predicting poor outcomes. This study highlights the critical condition of VAP patients in the ICU.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Ventilator-associated pneumonia (VAP) poses a significant threat in intensive care units (ICUs).
  • Acinetobacter baumannii is a challenging pathogen frequently implicated in VAP.
  • Understanding VAP epidemiology and outcomes is crucial for effective patient management.

Purpose of the Study:

  • To delineate the epidemiological features of Acinetobacter baumannii VAP.
  • To identify predictors of poor outcomes in patients with A. baumannii VAP.
  • To inform clinical strategies for managing this severe infection.

Main Methods:

  • A retrospective study was conducted in a Tunisian ICU over 16 months.
  • Adult patients diagnosed with A. baumannii VAP were included.
  • Data on patient demographics, clinical characteristics, VAP onset, and outcomes were analyzed.

Main Results:

  • Ninety-two patients with A. baumannii VAP were analyzed; 44.6% had multiple trauma.
  • The mean age was 44.5 years, with a mean SAPS II score of 39.
  • High ICU mortality (60.9%) was observed; VAP-related septic shock (OR 8.5) and hypertension (OR 5.8) predicted poor outcomes.

Conclusions:

  • Acinetobacter baumannii VAP is associated with substantial mortality.
  • Hemodynamic instability, specifically septic shock, is a key predictor of mortality.
  • Pre-existing hypertension also emerged as a significant risk factor for adverse outcomes.
Keywords:
Acinetobacter baumanniiEpidemiologyPrognosisVentilator-associated pneumonia

More Related Videos

Quantification, Viability Assessment, and Visualization Strategies for Acinetobacter Biofilms07:41

Quantification, Viability Assessment, and Visualization Strategies for Acinetobacter Biofilms

Published on: August 4, 2023

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.